Status:
COMPLETED
Breath Analysis in in Adults With Cystic Fibrosis (CF)
Lead Sponsor:
University of Zurich
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Exploratory comparative evaluation of exhaled breath composition in cystic fibrosis patients with age and gender-matched healthy adults in order to identify a disease-specific exhaled breath pattern a...
Detailed Description
Although there is some evidence that breath composition reflects aspects of CF pathology, so far a disease-specific molecular breath profile has not been identified. Real-time, whole breath analysis i...
Eligibility Criteria
Inclusion
- Clinical diagnosis of cystic fibrosis (for CF-patients)
- Age ≥ 18 years
Exclusion
- Previous lung transplantation (for CF-patients)
- Pulmonary exacerbation within the preceding 6 weeks (for CF-patients)
- Moribund or severe disease prohibiting protocol adherence (for CF-patients)
- Respiratory illness requiring physician consultation within the preceding 6 weeks (for controls)
- Chronic respiratory illness (for controls)
- Physical or intellectual impairment precluding informed consent or protocol adherence
- Pregnancy
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02209571
Start Date
October 1 2014
End Date
December 1 2015
Last Update
December 11 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich, Pulmonary Division
Zurich, Canton of Zurich, Switzerland, 8091